Format

Send to

Choose Destination
See comment in PubMed Commons below
Int J Oncol. 1993 Aug;3(2):245-51.

Prognostic value of periodic Acid-schiff (pas) staining of fine-needle aspirates from patients with primary hepatocellular-carcinoma.

Author information

  • 1CTR ADULT DIS,DEPT GASTROINTESTINAL ONCOL,HIGASHINARI KU,OSAKA 537,JAPAN. CTR ADULT DIS,DEPT PATHOL,HIGASHINARI KU,OSAKA 537,JAPAN. CTR ADULT DIS,DEPT GASTROENTEROL,HIGASHINARI KU,OSAKA 537,JAPAN.

Abstract

The relationships of cytological findings on periodic acid-Schiff (PAS) staining of fine-needle aspirates of hepatocellular carcinomas (HCC) with the length of survival of patients, their therapeutic response after transcatheter arterial embolization (TAE), and the tumor volume doubling time (TVDT) before chemoembolization were investigated in 74 patients with primary HCC. On the basis of cytologic findings on PAS-staining, HCC was classified into PAS-positive, mixed, and PAS-negative types. The two-year survival (70%) of patients with PAS-positive HCC was significantly longer than those of patients with the mixed or PAS-negative type of HCC. The TVDT of PAS-positive HCC was also significantly longer than that of the mixed type of HCC. These findings indicate that cytological findings on PAS-staining of HCC are useful in assessing the prognosis of patients with HCC.

PMID:
21573355
[PubMed]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Spandidos Publications
    Loading ...
    Support Center